Trial
NCT03764683
Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Bipolar Disorder
Intervention
Suvorexant (Belsomra)
Why stopped
Study was terminated due to COVID-19.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-21